BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9703804)

  • 21. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
    Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
    Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.
    Yamamoto J; Kosuge T; Saiura A; Sakamoto Y; Shimada K; Sano T; Takayama T; Sugawara Y; Yamaguchi T; Kokudo N; Makuuchi M
    Jpn J Clin Oncol; 2007 Apr; 37(4):287-95. PubMed ID: 17553819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis.
    Carr BI; Zajko A; Bron K; Orons P; Sammon J; Baron R
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-97-S6-99. PubMed ID: 9151923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of repeated percutaneous isolated liver chemoperfusion in local control of unresectable hepatocellular carcinoma.
    Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Muramatsu S; Kusunoki N; Sugimoto T; Suzuki Y; Kuroda Y; Saitoh Y
    Hepatogastroenterology; 1998; 45(24):1961-5. PubMed ID: 9951848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase I study of super high-dose chemotherapy for liver cancer with percutaneous isolated hepatic perfusion (PIHP) and peripheral blood stem cell transplantation (PBSCT)].
    Takahashi T; Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Takamatsu M; Tsuchida S; Sendou H; Suzuki Y; Kuroda Y
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1801-4. PubMed ID: 11086416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of percutaneous hepatic venous isolation and charcoal hemoperfusion for high-dose chemotherapy for hepatoma].
    Ku Y; Tominaga M; Maeda I; Iwasaki T; Kuroda Y; Saitoh Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1486-8. PubMed ID: 7574739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of multiple hepatocellular carcinoma complicated with N3 regional lymph node metastases preventing tumor progression by gradual introduction of lymph node excision and high-dose chemotherapy using percutaneous isolated hepatic perfusion].
    Samizo M; Ku Y; Kuroda Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1900-2. PubMed ID: 10560421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of Vp4 portal vein tumor thrombosis--a complete remission achieved with dual treatment of surgery plus percutaneous isolated hepatic perfusion].
    Chuma M; Fukumoto T; Kusunoki N; Tsuchida S; Kido M; Takahashi M; Tsugawa D; Awazu M; Kataoka Y; Matsumoto I; Hori Y; Kuroda D; Ku Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2300-2. PubMed ID: 21224554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?
    Chirica M; Scatton O; Massault PP; Aloia T; Randone B; Dousset B; Legmann P; Soubrane O
    Arch Surg; 2008 Jun; 143(6):538-43; discussion 543. PubMed ID: 18559745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of multiple hepatocellular carcinoma with rapidly progressing bilateral portal vein tumor thrombosis--a complete remission achieved with dual treatment of reductive surgery plus percutaneous isolated hepatic perfusion].
    Tsuchida S; Fukumoto T; Tominaga M; Iwasaki T; Kusunoki N; Sugimoto T; Kido M; Takebe A; Tanaka M; Hisoka K; Ku Y
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1818-20. PubMed ID: 16315951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of successful treatment of advanced hepatocellular carcinoma with tumor thrombi in the major portal branches and inferior vena cava with combined intraarterial 5-fluorouracil, adriamycin and cisplatin therapy].
    Ota H; Nagano H; Sakon M; Yamamoto T; Nakamura M; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1673-7. PubMed ID: 14619491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases.
    Ohnishi K; Nomura F; Ito S; Fujiwara K
    Hepatology; 1996 May; 23(5):994-1002. PubMed ID: 8621181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
    Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
    Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.